查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球 mRNA 合成与製造市场：按产品、服务和应用分类 - 预测（截至 2029 年）
市场调查报告书
商品编码
1574330

全球 mRNA 合成与製造市场：按产品、服务和应用分类 - 预测（截至 2029 年）

mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 344 Pages | 订单完成后即时交付

价格

全球mRNA合成和製造市场规模预计将从2024年的6.244亿美元增加到2029年的7.383亿美元，预测期内复合年增长率为3.4%。

mRNA 治疗药物被视为用于再生医学组织修復的有前途的下一代药物。非免疫抗原性mRNA 的开发可以透过使用修饰核苷来实现，从而提高安全性和有效性。透过改变 mRNA 的结构，研究人员可以透过体外转录创建稳定的、非免疫抗原性的mRNA。此外，有效的 mRNA 特异性发行策略对于这些治疗方法的进步至关重要。生物材料中 mRNA 的负载和释放过程对于组织修復应用至关重要，需要进一步完善才能充分发挥其潜力。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
单元 100万美元
部分 产品、应用、服务和最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

“从产品来看，转录耗材领域在 2023 年将占据 mRNA 合成和製造市场的最大份额。”

消耗品领域在整个预测期内占据主导地位，因为它对于 mRNA 合成和製造至关重要。与一次性投资的设备不同，消耗品必须定期补充，从而产生持续的需求。此外，虽然整个市场主要由 Thermo Fisher Scientific Inc.（美国）和 Sartorius AG（德国）提供的仪器推动，但更多公司活跃在 mRNA 合成和製造的耗材领域。

“在预测期内，mRNA 合成和修饰服务领域预计将以 mRNA 合成和製造市场中最高的速度增长。”

2023年，mRNA合成和修饰领域占据mRNA合成和製造市场的最大份额。 mRNA 合成和製造市场中 mRNA 合成和修饰服务的关键驱动因素是对客製化 mRNA 序列和修饰的需求不断增长，以提高治疗和疫苗候选物的功效和稳定性，并且需要专门的合成和修饰服务。随着 mRNA 技术用途的扩展，研究人员和开发人员正在寻求客製化的 mRNA 序列，这些序列可以针对特定的治疗效果进行优化，例如改善蛋白质表现或增强免疫反应。

“从 2024 年到 2029 年，亚太地区的 mRNA 合成和製造市场将以最高的复合年增长率增长。”

医疗成本上涨、印度、中国和日本等主要市场的研发扩大、人事费用低廉以及该地区有利的法规环境等因素预计将有助于市场成长。中国的 mRNA 合成和製造市场是由政府对生物技术创新的大量投资、国内生物技术基础设施的快速扩张以及国际合作的增加所推动的。最近的事态发展显示中国对推进 mRNA 技术的坚定承诺。

本报告针对全球mRNA合成和製造市场进行研究和分析，提供关键驱动和约束因素、竞争格局和未来趋势等资讯。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • mRNA合成与製造市场概述
  • 北美 mRNA 合成与製造市场：按产品和国家划分（2023 年）
  • mRNA 合成与製造服务市场：全球成长机会

第五章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 影响客户业务的趋势/干扰
  • 监管环境
    • 监管场景
    • 监管机构、政府机构和其他组织
  • 价值链分析
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 价格分析
    • 主要企业平均售价趋势：依设备分类
    • 消耗品平均售价变动趋势
    • 平均售价：按地区
  • 专利分析
  • 供应链分析
  • 生态系分析
  • 重大会议和活动（2024-2025）
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 投资金筹措场景
  • 人工智慧对 mRNA 合成和製造市场的影响

第六章 mRNA合成与製造市场：副产品

  • 介绍
  • 消耗品
    • 转移耗材
    • 精製耗材
    • 用于分析和表征的耗材
  • 用具

第七章 mRNA合成与製造产品市场：依应用分类

  • 介绍
  • 细胞/基因治疗
  • 疫苗
  • 其他用途

第 8 章 mRNA 合成与製造产品市场：依最终用户分类

  • 介绍
  • 製药和生物技术公司
  • 学术/研究机构
  • CRO・CDMO

第9章 mRNA合成与製造市场：依服务分类

  • 介绍
  • mRNA合成与修饰服务
  • mRNA精製服务
  • mRNA 分析和表征服务
  • 製造和规模化服务

第 10 章 mRNA 合成与製造服务市场：依最终用户分类

  • 介绍
  • 製药和生物技术公司
  • 学术/研究机构
  • 小型CRO/CDMO

第十一章 mRNA 合成与製造市场：按地区

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 瑞士
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 其他拉丁美洲
  • 中东
  • 非洲

第十二章竞争格局

  • 介绍
  • 主要企业策略/主要企业，2021年1月至2024年8月
  • 收益分析（2019-2023）
  • 市场占有率分析（2023）
    • mRNA合成/製造产品市场
    • mRNA合成/製造服务市场
  • 公司评价及财务指标
  • 品牌/服务比较
    • ALDEVRON LLC（丹纳赫公司）（美国）
    • 赛默飞世尔科技有限公司（美国）
    • TRILINK生物科技（美国）
    • 龙沙（瑞士）
    • 默克集团（德国）
  • 企业评价矩阵：主要企业（2023年）
  • 企业评估矩阵：Start-Ups/中小企业（2023）
  • 竞争场景

第十三章 公司简介

  • 主要企业
    • THERMO FISHER SCIENTIFIC INC.
    • DANAHER CORPORATION
    • MERCK KGAA
    • LONZA
    • MARVAI LIFESCIENCES
    • NEW ENGLAND BIOLABS
    • PROMEGA CORPORATION
    • GENSCRIPT
    • WUXI BIOLOGICS
    • TAKARA BIO INC.
    • SARTORIUS AG
    • GENEWIZ
    • TELESIS BIO INC.
    • ST PHARM
    • AGC BIOLOGICS
    • DR. REDDY'S LABORATORIES LTD.
  • 其他公司
    • ETHERNA
    • BOC SCIENCES
    • BIOMAY AG
    • CURIA GLOBAL, INC.
    • JENA BIOSCIENCE GMBH
    • ENZYNOMICS CO., LTD.
    • KANEKA EUROGENTEC SA
    • VERNAL BIOSCIENCES
    • CELLSCRIPT

第十四章附录

Product Code: BT 9194

The mRNA synthesis and manufacturing market is expected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024, at a CAGR of 3.4% during the forecast period. mRNA therapeutics hold promise as the next generation of drugs for tissue restoration in regenerative medicine. The development of non-immunogenic mRNA can be achieved through the use of modified nucleosides, which enhances safety and efficacy. By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription. Furthermore, effective delivery strategies tailored specifically for mRNA are crucial for the advancement of these therapies. The processes involved in loading and releasing mRNA from biomaterials are essential for their application in tissue restoration and require further refinement to maximize their potential.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsBy Product, Application, Service, and End Users
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"The transcription consumables segment accounted for the largest share by product segment in the mRNA synthesis and manufacturing market in 2023."

Based on product, the mRNA synthesis and manufacturing market is segmented into consumables, and instrument. In 2023, the consumables segment accounted for the largest share of mRNA synthesis and manufacturing market; this segment is further segmented into transcription consumables, purification consumables, and analysis & characterization consumables. Dominance of the consumables segment throughout the forecast period is attributed to the fact that they are essential for mRNA synthesis and manufacturing. Unlike instruments, which are a one-time investment, consumables must be replenished regularly, leading to continuous demand. Also, the entire market operates majorly on instruments offered by Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), whereas more companies operate in the consumables space for mRNA synthesis and manufacturing.

"The mRNA synthesis & modification service segment is expected to grow at the highest growth rate in the mRNA synthesis and manufacturing market throughout the forecast period."

Based on service, the mRNA synthesis and manufacturing market is segmented into mRNA synthesis & modification, mRNA purification, mRNA analysis & characterization, and manufacturing & scale-up. In 2023, the mRNA synthesis & modification segment accounted for the largest share of the mRNA synthesis and manufacturing market. A significant driver for the mRNA synthesis and modification services within the mRNA synthesis and manufacturing market is the growing need for customized mRNA sequences and modifications to enhance the efficacy and stability of therapeutic and vaccine candidates, which requires specialized synthesis and modification services. As the application of mRNA technology expands, researchers and developers increasingly seek tailored mRNA sequences that can be optimized for specific therapeutic outcomes, such as improved protein expression or enhanced immune response.

"The Asia Pacific region is growing at the highest CAGR in the mRNA synthesis and manufacturing market from 2024 to 2029."

The mRNA synthesis and manufacturing market is segmented into six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing regional segment in the global mRNA synthesis and manufacturing market, Factors such as rising healthcare expenditure; growing R&D expansion in key markets such as India, China, and Japan; low labor costs; and the favorable regulatory environment in the region are expected to contribute to market growth. China's mRNA synthesis and manufacturing market is driven by the country's substantial government investments in biotech innovation, rapid expansion of domestic biotech infrastructure, and increasing international collaborations. In recent developments, China has demonstrated a strong commitment to advancing mRNA technology.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
  • By Designation: Directors - 50%, Managers - 30%, and Others - 20%
  • By Region: North America -40%, Europe -35%, Asia-Pacific -20%, ROW -5%

List of Companies Profiled in the Report:

  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • GenScript (US)
  • New England Biolabs (US)
  • AldevronLLC. (Danaher Corporation) (US)
  • Promega Corporation (US)
  • Sartorius AG (Germany)
  • WuXi Biologics (China)
  • Takara Bio Inc. (Japan)
  • GENEWIZ (Azenta USInc.) (US)
  • TriLink BioTechnologies (US)
  • Lonza (Switzerland)
  • Telesis Bio Inc. (US)
  • Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India)
  • ST Pharm (South Korea)AGC Biologics (US)

Research Coverage:

This research report categorizes the mRNA synthesis and manufacturing market by Product (transcription consumables, purification consumables, analysis & characterization consumables, and instrument), Application (cell and gene therapy, vaccine, and other applications), End User (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the mRNA synthesis and manufacturing market. Competitive analysis of top players and upcoming startups in the mRNA synthesis and manufacturing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mRNA synthesis and manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mrna technology, advancements in mrna synthesis technology, increased outsourcing for mrna synthesis and modification, and collaborations among industry players), restraints (High production cost, stringent regulations), opportunities (Advancements in drug delivery technologies, increased government funding and private investment, applications in regenerative medicines), and challenges (Stability, storage, and manufacturing scalability) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the mRNA synthesis and manufacturing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the mRNA synthesis and manufacturing market
  • Competitive Assessment: Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), GenScript (US), New England Biolabs (US), Aldevron, LLC. (Danaher Corporation) (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), TriLink BioTechnologies (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 GLOBAL MARKET SIZE ESTIMATION
    • 2.2.2 INSIGHTS FROM PRIMARY SOURCES
    • 2.2.3 TOP-DOWN APPROACH
  • 2.3 GROWTH RATE PROJECTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MRNA SYNTHESIS & MANUFACTURING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT AND COUNTRY, 2023
  • 4.3 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: GLOBAL GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rise in clinical trials for mRNA vaccines
      • 5.2.1.2 Continuous improvements in design, delivery systems, and manufacturing processes
      • 5.2.1.3 Increased outsourcing of mRNA synthesis and production
      • 5.2.1.4 Advantages of mRNA-based technology over recombinant expression
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High production cost
      • 5.2.2.2 Stringent regulations
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Ongoing innovations in nanoparticles and cell-specific delivery technologies
      • 5.2.3.2 Expanding applications of mRNA technology
      • 5.2.3.3 Increased government funding and private investments
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stability, storage, and manufacturing scalability issues
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 REGULATORY LANDSCAPE
    • 5.4.1 REGULATORY SCENARIO
    • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 In vitro transcription
      • 5.6.1.2 Poly(A) tail synthesis
      • 5.6.1.3 RNA stabilization technologies
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 Next-generation sequencing
      • 5.6.2.2 Gene cloning and vector construction
      • 5.6.2.3 DNA amplification
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 Spectrophotometry
      • 5.6.3.2 Electrophoresis
      • 5.6.3.3 High-performance liquid chromatography
  • 5.7 PRICING ANALYSIS
    • 5.7.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT
    • 5.7.2 AVERAGE SELLING PRICE TREND FOR CONSUMABLES
    • 5.7.3 AVERAGE SELLING PRICE, BY REGION
  • 5.8 PATENT ANALYSIS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.12.2 BARGAINING POWER OF SUPPLIERS
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 THREAT OF SUBSTITUTES
    • 5.12.5 THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 KEY BUYING CRITERIA, BY END USER (PRODUCT)
  • 5.14 INVESTMENT AND FUNDING SCENARIO
  • 5.15 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET

6 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 TRANSCRIPTION CONSUMABLES
      • 6.2.1.1 mRNA synthesis kits
        • 6.2.1.1.1 Increasing demand for rapid and efficient mRNA vaccine development to augment growth
      • 6.2.1.2 mRNA profiling kits
        • 6.2.1.2.1 Growing need for precision medicine and personalized therapies to propel market
      • 6.2.1.3 RNA polymerases
        • 6.2.1.3.1 Growing demand for high-quality and scalable mRNA production to boost market
      • 6.2.1.4 Plasmid DNA/DNA templates
        • 6.2.1.4.1 Rapid growth of mRNA-based therapeutics and vaccines to expedite growth
      • 6.2.1.5 Nucleotides
        • 6.2.1.5.1 Need to support diverse research & development initiatives to promote growth
      • 6.2.1.6 Vectors
        • 6.2.1.6.1 Need for reliable and high-capacity vectors to propel market
      • 6.2.1.7 Other transcription consumables
    • 6.2.2 PURIFICATION CONSUMABLES
      • 6.2.2.1 Purification kits & reagents
        • 6.2.2.1.1 Rising focus on quality assurance to encourage growth
      • 6.2.2.2 Chromatography filters & membranes
        • 6.2.2.2.1 Growing emphasis on process optimization and cost-efficiency in large-scale production to drive market
      • 6.2.2.3 Other purification consumables
    • 6.2.3 ANALYSIS & CHARACTERIZATION CONSUMABLES
      • 6.2.3.1 Analysis kits & reagents
        • 6.2.3.1.1 Emerging applications of mRNA beyond vaccines to support growth
      • 6.2.3.2 Other analysis & characterization consumables
  • 6.3 INSTRUMENTS
    • 6.3.1 NEED TO REDUCE PRODUCTION COST AND HIGHER SCALABILITY TO PROMOTE GROWTH

7 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CELL & GENE THERAPIES
    • 7.2.1 RISING ADOPTION OF MRNA TECHNOLOGY TO TREAT GENETIC DISORDERS AND CANCER TO FUEL MARKET
  • 7.3 VACCINES
    • 7.3.1 INCREASING DEVELOPMENT AND DEPLOYMENT OF MRNA VACCINES TO ACCELERATE GROWTH
  • 7.4 OTHER APPLICATIONS

8 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 NEED TO RESPOND TO EMERGING INFECTIOUS DISEASES TO DRIVE MARKET
  • 8.3 ACADEMIC & RESEARCH INSTITUTIONS
    • 8.3.1 INCREASING INVESTMENTS IN RESEARCH TO EXPEDITE GROWTH
  • 8.4 CROS & CDMOS
    • 8.4.1 RISING DEMAND FOR OUTSOURCED SERVICES TO AID GROWTH

9 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE

  • 9.1 INTRODUCTION
  • 9.2 MRNA SYNTHESIS & MODIFICATION SERVICES
    • 9.2.1 GROWING NEED FOR CUSTOMIZED MRNA SEQUENCES AND MODIFICATIONS TO FUEL MARKET
  • 9.3 MRNA PURIFICATION SERVICES
    • 9.3.1 NEED FOR PERSONALIZED MRNA VACCINES TO BOOST MARKET
  • 9.4 MRNA ANALYSIS & CHARACTERIZATION SERVICES
    • 9.4.1 INCREASING REGULATORY SCRUTINY TO EXPEDITE GROWTH
  • 9.5 MANUFACTURING & SCALE-UP SERVICES
    • 9.5.1 GROWING TRANSITION FROM SMALL-SCALE RESEARCH & DEVELOPMENT TO LARGE-SCALE COMMERCIAL PRODUCTION TO DRIVE MARKET

10 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 RAPID DEVELOPMENT AND COMMERCIALIZATION OF MRNA-BASED PRODUCTS TO ENCOURAGE GROWTH
  • 10.3 ACADEMIC & RESEARCH INSTITUTIONS
    • 10.3.1 INCREASING EMPHASIS ON TRANSLATING MRNA-BASED DISCOVERIES INTO PRACTICAL APPLICATIONS TO AID GROWTH
  • 10.4 SMALL-SCALE CROS & CDMOS
    • 10.4.1 NEED FOR SPECIALIZED AND FLEXIBLE PRODUCTION IN BIOTECH COMPANIES AND EARLY-STAGE MRNA PROJECTS TO BOOST MARKET

11 MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Increasing demand for mRNA-based vaccines and therapeutics to accelerate growth
    • 11.2.3 CANADA
      • 11.2.3.1 Increasing collaborations between academic institutions and market players to spur growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Growing establishment of manufacturing sites to boost market
    • 11.3.3 UK
      • 11.3.3.1 Presence of state-of-the-art facilities to support growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Favorable government support for biopharmaceutical production to drive market
    • 11.3.5 SWITZERLAND
      • 11.3.5.1 Robust biotech sector and production facilities to promote growth
    • 11.3.6 ITALY
      • 11.3.6.1 Increasing collaborations among biotech firms and manufacturing facilities to aid growth
    • 11.3.7 SPAIN
      • 11.3.7.1 Growing investments in biotechnology to fuel market
    • 11.3.8 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Rapid expansion of domestic biotech sector to contribute to growth
    • 11.4.3 JAPAN
      • 11.4.3.1 Growing strategic investments in biotechnology infrastructure to boost market
    • 11.4.4 INDIA
      • 11.4.4.1 Booming biotech sector and international collaborations to augment growth
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Increased government funding in research and vaccine development to bolster growth
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Increased funding for strengthening infrastructure to sustain growth
    • 11.5.3 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST
    • 11.6.1 GROWING INVESTMENTS FROM PRIVATE SECTOR AND ACADEMIC RESEARCH INITIATIVES TO DRIVE MARKET
    • 11.6.2 MACROECONOMIC OUTLOOK IN MIDDLE EAST
  • 11.7 AFRICA
    • 11.7.1 GROWING INITIATIVES TO ENHANCE LOCAL PRODUCTION CAPABILITIES TO PROPEL MARKET
    • 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021-AUGUST 2024
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
    • 12.4.1 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET
    • 12.4.2 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 BRAND/SERVICE COMPARISON
    • 12.6.1 ALDEVRON LLC (DANAHER CORPORATION) (US)
    • 12.6.2 THERMO FISHER SCIENTIFIC INC. (US)
    • 12.6.3 TRILINK BIOTECHNOLOGIES (US)
    • 12.6.4 LONZA (SWITZERLAND)
    • 12.6.5 MERCK KGAA (GERMANY)
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Region footprint
      • 12.7.5.3 Product footprint
      • 12.7.5.4 Service footprint
      • 12.7.5.5 Application footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key startups/SMES
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT/SERVICE LAUNCHES
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 THERMO FISHER SCIENTIFIC INC.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product/Service launches
        • 13.1.1.3.2 Deals
        • 13.1.1.3.3 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 DANAHER CORPORATION
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product/Service launches
        • 13.1.2.3.2 Deals
        • 13.1.2.3.3 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 MERCK KGAA
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 LONZA
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
        • 13.1.4.3.2 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 MARVAI LIFESCIENCES
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Services offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product/Service launches
        • 13.1.5.3.2 Deals
        • 13.1.5.3.3 Expansions
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 NEW ENGLAND BIOLABS
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product/Service launches
    • 13.1.7 PROMEGA CORPORATION
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Expansions
        • 13.1.7.3.2 Other developments
    • 13.1.8 GENSCRIPT
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product/Service launches
        • 13.1.8.3.2 Deals
        • 13.1.8.3.3 Expansions
      • 13.1.8.4 MnM view
        • 13.1.8.4.1 Key strengths
        • 13.1.8.4.2 Strategic choices
        • 13.1.8.4.3 Weaknesses and competitive threats
    • 13.1.9 WUXI BIOLOGICS
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Expansions
    • 13.1.10 TAKARA BIO INC.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Services offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Product/Service launches
        • 13.1.10.3.2 Deals
    • 13.1.11 SARTORIUS AG
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products/Services offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Deals
    • 13.1.12 GENEWIZ
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products/Services offered
    • 13.1.13 TELESIS BIO INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products/Services offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Product/Service launches
        • 13.1.13.3.2 Deals
    • 13.1.14 ST PHARM
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products/Services offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Deals
    • 13.1.15 AGC BIOLOGICS
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products/Services offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Deals
        • 13.1.15.3.2 Expansions
    • 13.1.16 DR. REDDY'S LABORATORIES LTD.
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products/Services offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Expansions
  • 13.2 OTHER PLAYERS
    • 13.2.1 ETHERNA
    • 13.2.2 BOC SCIENCES
    • 13.2.3 BIOMAY AG
    • 13.2.4 CURIA GLOBAL, INC.
    • 13.2.5 JENA BIOSCIENCE GMBH
    • 13.2.6 ENZYNOMICS CO., LTD.
    • 13.2.7 KANEKA EUROGENTEC S.A.
    • 13.2.8 VERNAL BIOSCIENCES
    • 13.2.9 CELLSCRIPT

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 MRNA SYNTHESIS & MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 MRNA SYNTHESIS & MANUFACTURING MARKET: RISK ANALYSIS
  • TABLE 4 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 INDICATIVE LIST OF MRNA VACCINES IN CLINICAL TRIALS (AS OF JUNE 2023)
  • TABLE 6 INDICATIVE LIST OF MRNA-BASED DRUGS IN CLINICAL TRIALS (AS OF JUNE 2023)
  • TABLE 7 REGULATORY SCENARIO FOR MRNA SYNTHESIS & MANUFACTURING MARKET WORLDWIDE
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
  • TABLE 13 AVERAGE SELLING PRICE TREND FOR CONSUMABLES, 2021-2023 (USD)
  • TABLE 14 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
  • TABLE 15 MRNA SYNTHESIS & MANUFACTURING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2024
  • TABLE 16 MRNA SYNTHESIS & MANUFACTURING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 17 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 18 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 20 KEY BUYING CRITERIA, BY PRODUCT END USER
  • TABLE 21 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 22 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 23 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 EUROPE: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 28 TRANSCRIPTION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 NORTH AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 EUROPE: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 LATIN AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 MRNA SYNTHESIS KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 EUROPE: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 MRNA PROFILING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 EUROPE: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 RNA POLYMERASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 EUROPE: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 LATIN AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 PLASMID DNA/DNA TEMPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 NUCLEOTIDES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 VECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 EUROPE: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 LATIN AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 OTHER TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 EUROPE: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 PURIFICATION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 PURIFICATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 EUROPE: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 LATIN AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 PURIFICATION KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 EUROPE: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 LATIN AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 OTHER PURIFICATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 EUROPE: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 112 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 128 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 144 MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 EUROPE: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 MRNA PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 EUROPE: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 LATIN AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 EUROPE: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 LATIN AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 MANUFACTURING & SCALE-UP SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 160 NORTH AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 EUROPE: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 LATIN AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 165 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 181 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 187 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 190 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 191 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 193 MACROECONOMIC INDICATORS FOR NORTH AMERICA
  • TABLE 194 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 195 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 196 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 197 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 198 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 199 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 200 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 201 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 202 US: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 203 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 204 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 205 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 206 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 207 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 208 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 209 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 210 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 211 CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 212 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 215 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 216 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 217 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 218 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 219 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 220 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 221 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 222 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 223 MACROECONOMIC INDICATORS FOR EUROPE
  • TABLE 224 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 225 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 226 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 227 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 228 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 229 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 230 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 231 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 232 GERMANY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 233 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 234 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 235 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 236 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 237 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 238 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 239 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 240 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 241 UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 242 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 243 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 244 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 245 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 246 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 247 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 248 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 249 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 250 FRANCE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 251 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 252 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 253 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 254 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 255 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 256 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 257 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 258 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 259 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 260 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 261 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 262 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 263 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 264 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 265 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 266 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 267 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 268 ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 269 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 270 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 271 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 272 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 273 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 274 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 275 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 276 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 277 SPAIN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 278 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 279 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 280 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 281 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 282 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 283 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 284 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 285 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 286 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 287 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 291 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 297 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 298 MACROECONOMIC INDICATORS FOR ASIA PACIFIC
  • TABLE 299 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 300 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 301 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 302 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 303 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 304 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 305 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 306 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 307 CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 308 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 309 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 310 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 311 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 312 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 313 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 314 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 315 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 316 JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 317 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 318 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 319 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 320 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 321 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 322 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 323 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 324 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 325 INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 326 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 327 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 328 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 329 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 330 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 331 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 332 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 333 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 334 SOUTH KOREA: MRNA SYNTHESIS AND MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 335 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 336 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 337 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 338 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 339 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 340 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 341 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 342 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 343 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 344 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 346 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 348 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 349 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 350 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 351 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 352 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 353 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 354 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 355 MACROECONOMIC INDICATORS FOR LATIN AMERICA
  • TABLE 356 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 357 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 358 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 359 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 360 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 361 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 362 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 363 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 364 BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 365 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 366 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 368 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 369 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 370 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 371 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 372 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 373 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 374 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 375 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 376 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 377 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 378 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 379 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 380 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 381 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 382 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 383 MACROECONOMIC INDICATORS FOR MIDDLE EAST
  • TABLE 384 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 385 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 386 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 387 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 388 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
  • TABLE 389 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 390 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 391 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 392 AFRICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 393 MACROECONOMIC INDICATORS FOR AFRICA
  • TABLE 394 OVERVIEW OF STRATEGIES ADOPTED BY KEY MRNA SYNTHESIS & MANUFACTURING COMPANIES, JANUARY 2021-AUGUST 2024
  • TABLE 395 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: DEGREE OF COMPETITION, 2023
  • TABLE 396 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: RANKING ANALYSIS OF TOP 5 PLAYERS, 2023
  • TABLE 397 MRNA SYNTHESIS & MANUFACTURING MARKET: REGION FOOTPRINT
  • TABLE 398 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT FOOTPRINT
  • TABLE 399 MRNA SYNTHESIS & MANUFACTURING MARKET: SERVICE FOOTPRINT
  • TABLE 400 MRNA SYNTHESIS & MANUFACTURING MARKET: APPLICATION FOOTPRINT
  • TABLE 401 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY STARTUPS/SMES
  • TABLE 402 MRNA SYNTHESIS AND MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 403 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 404 MRNA SYNTHESIS & MANUFACTURING MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 405 MRNA SYNTHESIS & MANUFACTURING MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 406 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 407 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 408 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 409 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 410 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 411 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 412 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 413 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 414 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 415 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 416 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 417 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 418 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 419 MERCK KGAA: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 420 LONZA: COMPANY OVERVIEW
  • TABLE 421 LONZA: PRODUCTS/SERVICES OFFERED
  • TABLE 422 LONZA: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 423 LONZA: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 424 MARVAI LIFESCIENCES: COMPANY OVERVIEW
  • TABLE 425 MARVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED
  • TABLE 426 MARVAI LIFESCIENCES: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 427 MARVAI LIFESCIENCE: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 428 MARVAI LIFESCIENCES: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 429 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 430 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
  • TABLE 431 NEW ENGLAND BIOLABS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 432 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 433 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 434 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 435 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 436 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 437 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 438 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 439 GENSCRIPT: DEALS, JANUARY 2021- AUGUST 2024
  • TABLE 440 GENSCRIPT: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 441 WUXI BIOLOGICS: COMPANY OVERVIEW
  • TABLE 442 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
  • TABLE 443 WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 444 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 445 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 446 TAKARA BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 447 TAKARA BIO INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 448 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 449 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 450 SARTORIUS AG: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 451 GENEWIZ: COMPANY OVERVIEW
  • TABLE 452 GENEWIZ: PRODUCTS/SERVICES OFFERED
  • TABLE 453 TELESIS BIO INC.: COMPANY OVERVIEW
  • TABLE 454 TELESIS BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 455 TELESIS BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 456 TELESIS BIO INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 457 ST PHARM: COMPANY OVERVIEW
  • TABLE 458 ST PHARM: PRODUCTS/SERVICES OFFERED
  • TABLE 459 ST PHARM: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 460 AGC BIOLOGICS: COMPANY OVERVIEW
  • TABLE 461 AGC BIOLOGICS: PRODUCTS/SERVICES OFFERED
  • TABLE 462 AGC BIOLOGICS: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 463 AGC BIOLOGICS: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 464 DR. REDDY'S LABORATORIES LTD.: COMPANY OVERVIEW
  • TABLE 465 DR. REDDY'S LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 466 DR. REDDY'S LABORATORIES LTD.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 467 ETHERNA: COMPANY OVERVIEW
  • TABLE 468 BOC SCIENCES: COMPANY OVERVIEW
  • TABLE 469 BIOMAY AG: COMPANY OVERVIEW
  • TABLE 470 CURIA GLOBAL, INC.: COMPANY OVERVIEW
  • TABLE 471 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 472 ENZYNOMICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 473 KANEKA EUROGENTEC S.A.: COMPANY OVERVIEW
  • TABLE 474 VERNAL BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 475 CELLSCRIPT: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MRNA SYNTHESIS & MANUFACTURING MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MRNA SYNTHESIS & MANUFACTURING MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY RESPONDENT, DESIGNATION, AND REGION
  • FIGURE 4 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR PRODUCT MARKET), 2023
  • FIGURE 7 MARKET SIZE ESTIMATION: APPROACH 2 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR SERVICE MARKET), 2023
  • FIGURE 8 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 11 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: CAGR PROJECTIONS, 2024-2029
  • FIGURE 12 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: CAGR PROJECTIONS, 2024-2029
  • FIGURE 13 MRNA SYNTHESIS & MANUFACTURING MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 20 EXPANDING APPLICATIONS OF MRNA TECHNOLOGY TO DRIVE MARKET
  • FIGURE 21 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 22 MRNA SYNTHESIS & MODIFICATION TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 23 MRNA SYNTHESIS & MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MRNA SYNTHESIS & MANUFACTURING MARKET
  • FIGURE 25 MRNA SYNTHESIS & MANUFACTURING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE TREND, BY CONSUMABLES, 2021-2023 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
  • FIGURE 29 MRNA SYNTHESIS & MANUFACTURING MARKET: PATENT ANALYSIS, 2014-2024
  • FIGURE 30 MRNA SYNTHESIS & MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 MRNA SYNTHESIS & MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 MRNA SYNTHESIS & MANUFACTURING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 34 KEY BUYING CRITERIA, BY END USER (PRODUCT)
  • FIGURE 35 RESEARCH FUNDING FOR MRNA SYNTHESIS & MANUFACTURING BY INSTITUTES AND CENTERS, 2021-2024 (USD MILLION)
  • FIGURE 36 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET
  • FIGURE 37 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY VOLUME, 2022-2029
  • FIGURE 38 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
  • FIGURE 40 MRNA SYNTHESIS & MANUFACTURING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023 (USD MILLION)
  • FIGURE 41 MRNA SYNTHESIS & MANUFACTURING MARKET SHARE ANALYSIS, 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 MRNA SYNTHESIS & MANUFACTURING MARKET: BRAND/SERVICE COMPARISON
  • FIGURE 45 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 46 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY FOOTPRINT
  • FIGURE 47 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 51 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 52 MARVAI LIFESCIENCES: COMPANY SNAPSHOT (2023)
  • FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 54 WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
  • FIGURE 55 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GENEWIZ: COMPANY SNAPSHOT (2023)
  • FIGURE 58 TELESIS BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 ST PHARM: COMPANY SNAPSHOT (2023)
  • FIGURE 60 DR. REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT (2023)